Skip to content

Syndax Pharmaceuticals Inc

Public company
Headquarters
NEW YORK, New York
Ticker
SNDX
CIK
0001395937

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

2
1 appointment, 1 departure

Last event

Nov 2, 2026
Executive departureCFO departs: Keith A. Goldan

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CFOKeith A. GoldanNov 2, 2026Departed
principal accounting and financial officer and treasurerAaron A. OndreyNov 2, 2026Appointed

Related companies

Same industry and state, with recent events.

  1. Executive departure

    CFO departs: Keith A. Goldan

    Keith A. Goldan, Chief Financial Officer, principal accounting and financial officer and treasurer of Syndax Pharmaceuticals Inc, retires the role, effective November 9, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Financial Officer, principal accounting and financial officer and treasurer

    Source: SEC 8-K, filed Nov 2, 2026

  2. Executive appointment

    principal accounting and financial officer and treasurer appointed: Aaron A. Ondrey

    Aaron A. Ondrey was named principal accounting and financial officer and treasurer of Syndax Pharmaceuticals Inc. The company reported the change in an 8-K that cites Item 5.02.

    Role: principal accounting and financial officer and treasurer

    Source: SEC 8-K, filed Nov 2, 2026

Last verified Nov 8, 2026